Metabolic-Fit / 100
Next Vial review
The plan selector is clean: $199 a month, or $169, $149 and $99 on three-, six- and twelve-month plans, and every one of those divisions checks out to the dollar. Semaglutide and tirzepatide cost exactly the same, which is unusual. Then look at the top of the same page, where the headline reads "Doctor-Led Weight Loss Plans as Low as $249.97/Month" — a figure the selector never shows, and two and a half times the cheapest plan it offers.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
Next Vial at a glance
- Semaglutide
- $199/mo month to month
- Tirzepatide
- $199/mo month to month
- Coverage
- Not published
- Brand-name
- Compounded only
How we scored Next Vial
Every factor comes from Next Vial's own published pricing, disclosures and oversight, and the six combine into the 53/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Cost is unpredictable or sits at the premium end.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Support is thin once the prescription ships.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- August 2026
- Confidence
- high
- Primary source
- www.nextvial.com/product/glp-1-medications
Read on 18 August 2026. Next Vial LLC prices its GLP-1 plans clearly and correctly: $199 a month month-to-month, $169 on a three-month plan at $507, $149 on six months at $894, and $99 on twelve months at $1,188. A microdose route runs $159, $139 and $79 on three-, six- and twelve-month plans, with no one-month option. Every division was recomputed and every one is exact. Semaglutide and tirzepatide cost the same, so switching molecules costs nothing — the second seller on this page to do that. One thing on the same page contradicts all of it: the headline advertises "Doctor-Led Weight Loss Plans as Low as $249.97/Month", a figure that appears nowhere in the selector and is two and a half times its cheapest plan. Free delivery, no membership and no insurance are stated on the homepage, and it carries a LegitScript badge. No state list or compounding pharmacy is published. It has no FDA warning letter. ⚠ Its Terms are shared with ClickSlim and, as of 19 August, with LevelUp Rx, Lumen Meds and NuviaRx — 88 to 92% identical across those three, with a single shared block running to 12,076 characters. Two of the four resolve to the same IP address, and two carry the same orphan price line that contradicts both their own selectors. Recorded as four brands sharing a document, an origin server and a template; no filing, officer or address has been found, so nothing further is claimed.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $199 | One month, billed monthly$199/mo month to month; $169 on a 3-month plan ($507), $149 on 6 months ($894) and $99 on 12 months ($1,188). Every division is exact. ⛔ The same page's hero advertises "as low as $249.97/Month", a figure the selector never shows and 2.5x the cheapest plan. |
| Compounded tirzepatide | $199 | One month, billed monthlyThe same $199 as semaglutide — the plan selector charges one price whichever molecule is chosen. |
| Compounded semaglutide | $99 | 12-month plan$1,188 paid up front for twelve months, the deepest tier and marked BEST SELLER. |
| Compounded semaglutide | $159 | Microdose, 3-month plan$477 for three months. The microdose route has no one-month option at all; it starts at three. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Next Vial's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- A genuine month-to-month option at $199, not just prepaid plans
- Every plan division recomputes exactly — $507, $894, $1,188, $477, $834 and $948 all divide cleanly
- Semaglutide and tirzepatide are the same price, so switching molecules costs nothing
- A microdose route is offered for both molecules
- Free delivery, no membership and no insurance, all stated on the homepage
- Carries a LegitScript certification badge
The caveats
- ⛔ The headline on the same page says "as low as $249.97/Month", which is higher than every plan the selector offers
- The $99 rate requires $1,188 paid up front
- The microdose route has no one-month option — it starts at three months
- No state list is published
- No compounding pharmacy is named
- Its Terms are 88 to 92% identical to three other sellers', two of them on the same IP address
Next Vial for mothers: our verdict
The plan selector is clean: $199 a month, or $169, $149 and $99 on three-, six- and twelve-month plans, and every one of those divisions checks out to the dollar. Semaglutide and tirzepatide cost exactly the same, which is unusual. Then look at the top of the same page, where the headline reads "Doctor-Led Weight Loss Plans as Low as $249.97/Month" — a figure the selector never shows, and two and a half times the cheapest plan it offers. It runs about $199/month.
We weigh Next Vial the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.
What Next Vial costs, in full
- Compounded semaglutide — One month, billed monthly: $199/mo
- Compounded tirzepatide — One month, billed monthly: $199/mo
- Compounded semaglutide — 12-month plan: $99/mo
- Compounded semaglutide — Microdose, 3-month plan: $159/mo
That lands within a few dollars of the ~$179/month median across the providers we track, so the monthly cost isn't what should decide this one either way. Weigh it instead on postpartum and breastfeeding timing and PCOS and insulin resistance, and on what the price actually includes — a lower number that leaves out labs, visits or shipping is not the cheaper option.
Next Vial says the price covers the provider visit, the medication and shipping. That is the comparison that matters at this price: two providers a few dollars apart can differ by a hundred a month once the extras are counted, so line up what each one bundles before you decide.
The medications Next Vial prescribes
Next Vial prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Next Vial fits — and where it doesn't — for mothers
A good fit if…
- switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.
Oversight, safety, and what we could verify
Everything Next Vial states publicly checked out at last review: pricing, pharmacies and clinical network were all verifiable. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
Next Vial is a reasonable option — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: A mother who wants a real month-to-month price and a large discount if she can commit to a year.
Alternatives to Next Vial
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing Next Vial
Head-to-head & alternatives
Next Vial, answered
- How much does Next Vial cost?
- At last review, Next Vial's lowest ongoing compounded rate was about $199 a month — $199/mo month to month for semaglutide, $199/mo month to month for tirzepatide. This market re-prices often, so check the current all-in figure at the source before committing.
- Is Next Vial safe to use while breastfeeding?
- Nothing in this class — compounded or brand — has been established as safe in pregnancy or lactation, and every label advises against use. Next Vial is not an exception to that. Plan a GLP-1 for after weaning and settle the timing with your own clinician.
- Does Next Vial offer both semaglutide and tirzepatide?
- Yes — Next Vial offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does Next Vial rank for mothers?
- Next Vial scores 53/100 on our Metabolic-Fit Score and sits at #58. That score is a weighted read of six things mothers actually have to care about. CoreAge Rx currently leads it — see how they compare.
Pricing, states and verification reflect Next Vial's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.